Bevacizumab in High-Risk Penetrating Keratoplasty

Dr. Matt Feng is joined by Dr. Thomas H. Dohlman to discuss the effectiveness of topical and subconjunctival bevacizumab in suppressing vascularization in graft and host bed after high-risk corneal transplantation, from his Ophthalmology Science article “Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation” Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation. Dohlman, Thomas H. et al. Ophthalmology Science, Volume 4, Issue 4.

Om Podcasten

Join Ophthalmology’s social media editors as they interview authors and editors of the American Academy of Ophthalmology’s journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science.